InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Scott Kathleen D., 董事. Officer active across 2 companies, notably Dermata Therapeutics, Inc.. Cumulatively, 9 disclosures have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €50k. History available since 7 April 2022. The latest transaction was filed on 21 August 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Scott Kathleen D. is Administrateur of Dermata Therapeutics, Inc. and Chief Financial Officer of ARS Pharmaceuticals, Inc. The 9 filings recorded run from 2022-04-08 to 2026-06-16, and across the sampled recent filings, total buying amounts to EUR 49786, with Levée d'options as the most frequent transaction nature.